These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6861442)

  • 1. Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration.
    Pedersen KE; Christiansen BD; Kjaer K; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1983 Jul; 34(1):8-13. PubMed ID: 6861442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of calcium antagonists on plasma digoxin concentration.
    Pedersen KE
    Acta Med Scand Suppl; 1984; 681():31-6. PubMed ID: 6587754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-verapamil interaction.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1981 Sep; 30(3):311-6. PubMed ID: 7273594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Pedersen KK
    Eur J Clin Pharmacol; 1982; 22(2):123-7. PubMed ID: 7094982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of verapamil on the inotropism and pharmacokinetics of digoxin.
    Pedersen KE; Thayssen P; Klitgaard NA; Christiansen BD; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 25(2):199-206. PubMed ID: 6628501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil and digoxin: interactions in the rat.
    Kaplanski J; Weinhouse E; Topaz M; Genchik G
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):377-88. PubMed ID: 6665298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil-induced changes in digoxin kinetics in cirrhosis.
    Maragno I; Gianotti C; Tropeano PF; Rodighiero V; Gaion RM; Paleari C; Prandoni R; Menozzi L
    Eur J Clin Pharmacol; 1987; 32(3):309-11. PubMed ID: 3595704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics.
    Johnson BF; Wilson J; Marwaha R; Hoch K; Johnson J
    Clin Pharmacol Ther; 1987 Jul; 42(1):66-71. PubMed ID: 2954736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides.
    Hedman A; Meijer DK
    J Hepatol; 1998 Feb; 28(2):240-9. PubMed ID: 9514537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between verapamil and beta-methyldigoxin. Study by 86Rubidium uptake in erythrocytes.
    De Cesaris R; Balestrazzi M; Chiarappa R; Ranieri G
    Int J Clin Pharmacol Res; 1983; 3(2):107-9. PubMed ID: 6679512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of determination of intraerythrocytic sodium and potassium concentrations versus plasma digoxin concentration in digoxin intoxication.
    Pedersen KE; Koldkjaer O; Berndtz NH; Hvidt S; Kjaer K; Midtskov C; Sanchez G
    Acta Med Scand; 1983; 213(5):357-62. PubMed ID: 6880858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and tissue levels of digoxin in the rat following pretreatment with verapamil.
    Weinhouse E; Kaplanski J; Genchik G
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):469-72. PubMed ID: 3992024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of verapamil on serum digoxin concentration.
    Klein HO; Lang R; Weiss E; Di Segni E; Libhaber C; Guerrero J; Kaplinsky E
    Circulation; 1982 May; 65(5):998-1003. PubMed ID: 7074765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-verapamil interaction: in vitro studies in rat tissue.
    Koren G; Soldin S; MacLeod SM
    J Cardiovasc Pharmacol; 1983; 5(3):443-5. PubMed ID: 6191144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
    Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
    Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.
    Ford AR; Aronson JK; Grahame-Smith DG; Carver JG
    Br J Clin Pharmacol; 1979 Aug; 8(2):125-34. PubMed ID: 486289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nifedipine on digoxin kinetics in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Kjaer K; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1982 Nov; 32(5):562-5. PubMed ID: 7127997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alprazolam on digoxin kinetics and creatinine clearance.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B
    Clin Pharmacol Ther; 1985 Nov; 38(5):595-8. PubMed ID: 2865030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin interactions. The influence of quinidine and verapamil on the pharmacokinetics and receptor binding of digitalis glycosides.
    Pedersen KE
    Acta Med Scand Suppl; 1985; 697():1-40. PubMed ID: 3863471
    [No Abstract]   [Full Text] [Related]  

  • 20. The diltiazem-digoxin interaction.
    Rameis H; Magometschnigg D; Ganzinger U
    Clin Pharmacol Ther; 1984 Aug; 36(2):183-9. PubMed ID: 6744777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.